EOLS
Price
$9.27
Change
+$0.06 (+0.65%)
Updated
Jul 3 closing price
Capitalization
846.82M
24 days until earnings call
TAK
Price
$15.34
Change
-$0.08 (-0.52%)
Updated
Jul 3 closing price
Capitalization
43.11B
24 days until earnings call
Interact to see
Advertisement

EOLS vs TAK

Header iconEOLS vs TAK Comparison
Open Charts EOLS vs TAKBanner chart's image
Evolus
Price$9.27
Change+$0.06 (+0.65%)
Volume$424.23K
Capitalization846.82M
Takeda Pharmaceutical
Price$15.34
Change-$0.08 (-0.52%)
Volume$1.65M
Capitalization43.11B
EOLS vs TAK Comparison Chart in %
Loading...
EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EOLS vs. TAK commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EOLS is a Hold and TAK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (EOLS: $9.27 vs. TAK: $15.34)
Brand notoriety: EOLS and TAK are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: EOLS: 40% vs. TAK: 82%
Market capitalization -- EOLS: $846.82M vs. TAK: $43.11B
EOLS [@Pharmaceuticals: Other] is valued at $846.82M. TAK’s [@Pharmaceuticals: Other] market capitalization is $43.11B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EOLS’s FA Score shows that 0 FA rating(s) are green whileTAK’s FA Score has 2 green FA rating(s).

  • EOLS’s FA Score: 0 green, 5 red.
  • TAK’s FA Score: 2 green, 3 red.
According to our system of comparison, TAK is a better buy in the long-term than EOLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EOLS’s TA Score shows that 4 TA indicator(s) are bullish while TAK’s TA Score has 6 bullish TA indicator(s).

  • EOLS’s TA Score: 4 bullish, 3 bearish.
  • TAK’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, both EOLS and TAK are a good buy in the short-term.

Price Growth

EOLS (@Pharmaceuticals: Other) experienced а -0.43% price change this week, while TAK (@Pharmaceuticals: Other) price change was +1.86% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Reported Earning Dates

EOLS is expected to report earnings on Jul 30, 2025.

TAK is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TAK($43.1B) has a higher market cap than EOLS($847M). TAK YTD gains are higher at: 15.861 vs. EOLS (-16.033). TAK has higher annual earnings (EBITDA): 1.01T vs. EOLS (-41.81M). TAK has more cash in the bank: 317B vs. EOLS (62.8M). EOLS has less debt than TAK: EOLS (127M) vs TAK (4.66T). TAK has higher revenues than EOLS: TAK (4.17T) vs EOLS (202M).
EOLSTAKEOLS / TAK
Capitalization847M43.1B2%
EBITDA-41.81M1.01T-0%
Gain YTD-16.03315.861-101%
P/E RatioN/A36.79-
Revenue202M4.17T0%
Total Cash62.8M317B0%
Total Debt127M4.66T0%
FUNDAMENTALS RATINGS
EOLS vs TAK: Fundamental Ratings
EOLS
TAK
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
10
Undervalued
PROFIT vs RISK RATING
1..100
71100
SMR RATING
1..100
10085
PRICE GROWTH RATING
1..100
8251
P/E GROWTH RATING
1..100
10019
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TAK's Valuation (10) in the Pharmaceuticals Major industry is significantly better than the same rating for EOLS (87). This means that TAK’s stock grew significantly faster than EOLS’s over the last 12 months.

EOLS's Profit vs Risk Rating (71) in the Pharmaceuticals Major industry is in the same range as TAK (100). This means that EOLS’s stock grew similarly to TAK’s over the last 12 months.

TAK's SMR Rating (85) in the Pharmaceuticals Major industry is in the same range as EOLS (100). This means that TAK’s stock grew similarly to EOLS’s over the last 12 months.

TAK's Price Growth Rating (51) in the Pharmaceuticals Major industry is in the same range as EOLS (82). This means that TAK’s stock grew similarly to EOLS’s over the last 12 months.

TAK's P/E Growth Rating (19) in the Pharmaceuticals Major industry is significantly better than the same rating for EOLS (100). This means that TAK’s stock grew significantly faster than EOLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EOLSTAK
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
55%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
47%
Momentum
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
40%
MACD
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
38%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
43%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
38%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 7 days ago
43%
Declines
ODDS (%)
Bearish Trend 24 days ago
80%
Bearish Trend 20 days ago
44%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
79%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
74%
Bullish Trend 4 days ago
39%
View a ticker or compare two or three
Interact to see
Advertisement
EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TICHX28.930.28
+0.98%
Nuveen Large Cap Responsible Eq I
PAILX8.330.07
+0.85%
PGIM Jennison Intl Sm-Md Cap Opps C
PRACX48.580.40
+0.83%
Putnam Research C
WWLAX14.130.10
+0.71%
Westwood Quality Value Fund A
MCCPX22.190.06
+0.27%
BlackRock Balanced Investor C

EOLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, EOLS has been loosely correlated with AGBIF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if EOLS jumps, then AGBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EOLS
1D Price
Change %
EOLS100%
+0.65%
AGBIF - EOLS
38%
Loosely correlated
N/A
AMRX - EOLS
34%
Loosely correlated
+0.60%
ALKS - EOLS
31%
Poorly correlated
-0.52%
NBIX - EOLS
29%
Poorly correlated
-0.22%
AQST - EOLS
28%
Poorly correlated
+1.09%
More

TAK and

Correlation & Price change

A.I.dvisor indicates that over the last year, TAK has been loosely correlated with HLN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TAK jumps, then HLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TAK
1D Price
Change %
TAK100%
-0.52%
HLN - TAK
40%
Loosely correlated
-0.10%
RDY - TAK
25%
Poorly correlated
+1.34%
SNOA - TAK
24%
Poorly correlated
+1.71%
EOLS - TAK
23%
Poorly correlated
+0.65%
KHTRF - TAK
22%
Poorly correlated
+4.50%
More